David Windley
Stock Analyst at Jefferies
(3.57)
# 793
Out of 5,182 analysts
204
Total ratings
64.71%
Success rate
13.01%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Upgrades: Buy | $175 → $135 | $114.19 | +18.22% | 16 | Feb 23, 2026 | |
| MEDP Medpace Holdings | Upgrades: Buy | $560 | $498.34 | +12.37% | 7 | Feb 13, 2026 | |
| HUM Humana | Maintains: Buy | $310 → $235 | $177.83 | +32.15% | 20 | Feb 12, 2026 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $255 | $173.26 | +47.18% | 6 | Feb 6, 2026 | |
| UNH UnitedHealth Group | Maintains: Buy | $418 → $340 | $277.26 | +22.63% | 28 | Jan 28, 2026 | |
| DEO Diageo | Downgrades: Neutral | n/a | $73.32 | - | 1 | Dec 3, 2025 | |
| FTRE Fortrea Holdings | Maintains: Hold | $7 → $9.5 | $9.44 | +0.69% | 3 | Sep 9, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $142 → $195 | $173.89 | +12.14% | 20 | Sep 9, 2025 | |
| STE STERIS | Initiates: Hold | $263 | $218.71 | +20.25% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $0.60 | +354.70% | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $64 → $61 | $35.11 | +73.74% | 28 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $12 | $11.92 | +0.67% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $402 → $422 | $270.02 | +56.28% | 17 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $297 | $139.38 | +113.09% | 23 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $0.27 | +1,305.55% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $300.74 | +100.84% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $452.07 | -17.05% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $14.96 | +3.61% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $173.98 | +55.19% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $5.41 | +186.51% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $254.80 | +110.36% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $13.73 | +111.22% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $5.27 | +4,605.88% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.76 | - | 5 | Oct 9, 2017 |
ICON Public Limited Company
Feb 23, 2026
Upgrades: Buy
Price Target: $175 → $135
Current: $114.19
Upside: +18.22%
Medpace Holdings
Feb 13, 2026
Upgrades: Buy
Price Target: $560
Current: $498.34
Upside: +12.37%
Humana
Feb 12, 2026
Maintains: Buy
Price Target: $310 → $235
Current: $177.83
Upside: +32.15%
IQVIA Holdings
Feb 6, 2026
Maintains: Buy
Price Target: $270 → $255
Current: $173.26
Upside: +47.18%
UnitedHealth Group
Jan 28, 2026
Maintains: Buy
Price Target: $418 → $340
Current: $277.26
Upside: +22.63%
Diageo
Dec 3, 2025
Downgrades: Neutral
Price Target: n/a
Current: $73.32
Upside: -
Fortrea Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $7 → $9.5
Current: $9.44
Upside: +0.69%
Charles River Laboratories International
Sep 9, 2025
Upgrades: Buy
Price Target: $142 → $195
Current: $173.89
Upside: +12.14%
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $218.71
Upside: +20.25%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $0.60
Upside: +354.70%
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $35.11
Upside: +73.74%
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $11.92
Upside: +0.67%
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $270.02
Upside: +56.28%
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $139.38
Upside: +113.09%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $0.27
Upside: +1,305.55%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $300.74
Upside: +100.84%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $452.07
Upside: -17.05%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $14.96
Upside: +3.61%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $173.98
Upside: +55.19%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $5.41
Upside: +186.51%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $254.80
Upside: +110.36%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $13.73
Upside: +111.22%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $5.27
Upside: +4,605.88%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $0.76
Upside: -